Strides Shasun has completed acquisition of a controlling stake in Australia-based Generic Partners Holdings. The company has acquired 51 per cent stake in Australia’s Generic Partners Holdings Co for AUD 15 million and a commitment of AUD 10 million to fund future R&D. The acquisition provides Shasun immediate access to 47 commercialised marketing authorisations. It also provides access to 22 registrations pending approval with Therapeutic Goods Administration (TGA) and strong pipeline of 32 molecules including host of drugs going off patent in future.
Company Profile : Shasun Pharmaceuticals Ltd
Leave a Reply